Kairos Pharma (KAPA) Total Current Liabilities (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Total Current Liabilities came in at $199000.0 in Q4 2025, down 79.94% YoY from $992000.0 in Q4 2024, and down 70.56% on a QoQ basis from $676000.0 in Q2 2025.
Kairos Pharma (KAPA) Total Current Liabilities (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Total Current Liabilities data on file, last reported at $199000.0 in Q4 2025.
- Quarterly Total Current Liabilities fell 79.94% year-over-year to $199000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $199000.0 (down 79.94% YoY) and the FY2025 annual result came in at $199000.0, down 79.94% from the prior year.
- Total Current Liabilities declined to $199000.0 in Q4 2025, from $676000.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $2.4 million in Q4 2023 to a low of $199000.0 in Q4 2025.
- A 3-year average of $1.1 million and a median of $898500.0 in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities plunged 58.75% — and 2025, when it plunged 79.94%.
- Tracing KAPA's Total Current Liabilities over 3 years: stood at $2.4 million in 2023, then sank by 58.75% to $992000.0 in 2024, then sank by 79.94% to $199000.0 in 2025.
- The last three Total Current Liabilities figures came in at $199000.0 (Q4 2025), $676000.0 (Q2 2025), and $805000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | 199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 199,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 805,000.00 |
| Dec 31, 2024 | 992,000.00 |
| Sep 30, 2024 | 1.67 Mn |
| Dec 31, 2023 | 2.41 Mn |